用依维莫司治疗的伴有多发转移的侵袭性卵巢神经内分泌肿瘤：一例报告
Aggressive neuroendocrine tumor of the ovary with multiple metastases treated with everolimus: A case report.
作者信息
Kaiho-Sakuma Michiko, Toyoshima Masafumi, Watanabe Mika, Toki Asami, Kameda Satomi, Minato Takamichi, Niikura Hitoshi, Yaegashi Nobuo
机构信息
Department of Obstetrics and Gynecology, Tohoku University Hospital, Sendai, Japan.
Department of Pathology, Tohoku University Hospital, Sendai, Japan.
出版信息
Gynecol Oncol Rep. 2018 Jan 4;23:20-23. doi: 10.1016/j.gore.2018.01.002. eCollection 2018 Feb.
•Neuroendocrine tumors (NETs) frequently occur in the lungs or the gastrointestinal tract; they are uncommon in the ovary.•The mammalian target of rapamycin (mTOR) pathway has been reported as a treatment for advanced NETs.•We describe a patient with an aggressive primary ovarian NET, successfully treated with everolimus (an mTOR inhibitor).
•神经内分泌肿瘤（NETs）常发生于肺部或胃肠道；在卵巢中较为罕见。
•哺乳动物雷帕霉素靶蛋白（mTOR）通路已被报道可用于治疗晚期NETs。
•我们描述了一名患有侵袭性原发性卵巢NET的患者，用依维莫司（一种mTOR抑制剂）成功治疗。
Zotero 插件